DNA microarrays in herbal drug research

Evidence-based Complementary and Alternative Medicine

Volumn 3, Issue 4, 2006, Pages 447-457

  Chavan, Preeti ^a   Joshi, Kalpana ^a   Patwardhan, Bhushan ^a  

^a UNIVERSITY OF PUNE   (India)

Author keywords

Drug discovery; Evidence based medicine; Gene expression; Genotyping; Pharmacodynamics; Transcription profiling

Indexed keywords

ANEMARRHENA ASPHODELOIDES EXTRACT; BERBERINE; BOSWELLIA SERRATA EXTRACT; CENTELLA ASIATICA EXTRACT; COCAINE; COPTIDIS RHIZOMA EXTRACT; DNA; DOCETAXEL; ESTRAMUSTINE; FLAVONOID; FOLIC ACID ANTAGONIST; GINKGO BILOBA EXTRACT; GINKGOLIDE B; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IMATINIB; IMIPRAMINE; METFORMIN; NATURAL PRODUCT; PAEONIA EXTRACT; PEMETREXED; PLANT EXTRACT; QINGYANGSHENYLYCOSIDE; SALICYLIC ACID; SAPONIN DERIVATIVE; SI JUN ZI; SYZYGIUM AROMATICUM EXTRACT; TRIPTERYGIUM HYPOGLAUCUM EXTRACT; TRITERPENE DERIVATIVE; UNINDEXED DRUG;

AUDIOGENIC SEIZURE; CHROMOSOME ABERRATION; CLINICAL TRIAL; COMPARATIVE GENOMIC HYBRIDIZATION; CONNECTIVE TISSUE DISEASE; DNA MICROARRAY; DNA POLYMORPHISM; DNA TRANSCRIPTION; DRUG MECHANISM; DRUG RESEARCH; DRUG RESPONSE; GENE EXPRESSION PROFILING; GENE MUTATION; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; MAJOR DEPRESSION; MICROANGIOPATHY; MUTATIONAL ANALYSIS; PHARMACOGENOMICS; PHARMACOGNOSY; POPULATION GENETICS; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SPECIES IDENTIFICATION; TOXICOGENETICS; WOUND HEALING IMPAIRMENT;

EID: 33845444536     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nel075     Document Type: Review

References (127)

1. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70.
2. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996;93:10614-19.
3. Taniguchi M, Miura K, Iwao H, Yamanaka S. Quantitative assessments of DNA microarrays-comparison with northern blot analyses. Genomics 2001;71:34-9.
4. Yamamoto M, Wakatsuki T, Hada A, Ryo A. Use of serial analysis of gene expression (SAGE) technology. J Immunol Methods 2001;250:45-66.
5. Bertelsen AH, Velculescu VE. High-throughput gene expression analysis using SAGE. Drug Discov Today 1998;3:152-9.
6. Lee Y, Sultana R, Pertea G, Cho J, Karamycheva S, Tsai J, et al. Cross-referencing eukaryotic genomes: TIGR Orthologous Gene Alignments (TOGA). Genome Res 2002;12:493-502.
7. Sogayar MC, Camargo AA, Bettoni F, Carraro DM, Pires LC, Parmigiani RB. Ludwig-FAPESP transcript finishing initiative: a transcript finishing initiative for closing gaps in the human transcriptome. Genome Res 2004;14:1413-23.
8. Debouck C, Goodfellow PN. DNA microarrays in drug discovery and development. Nat Genet 1999;21:48-50.
9. Gerhold DL, Jensen RV, Gullans SR. Better therapeutics through microarrays. Nat Genet 2002;32:547-51.
10. Reynolds MA. Microarray technology GEM microarrays and drug discovery. J Ind Microbiol Biotechnol 2002;28:180-5.
11. Koppal T. Microarrays: migrating from discovery to diagnostics. Drug Discov Dev 2004;7:30-4.
12. Gebauer M. Microarray applications: emerging technologies and perspectives. Drug Discov Today 2004;9:915-17.
13. Huang JX, Mehrens D, Wiese R, Lee S, Tam SW, Daniel S, et al. High-throughput genomic and proteomic analysis using microarray technology. Clin Chem 2001;47:1912-16.
14. Merchant M, Weinberger SR. Recent advancements in surface enhanced laser desorption/ionization time-of-flight mass spectrometry. Electrophoresis 2000;21:1164-77.
15. Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P, et al. Global analysis of protein activities using proteome chips. Science 2001;293:2101-5.
16. Stoll D, Templin MF, Bachmann J, Joos TO. Protein microarrays: applications and future challenges. Curr Opin Drug Discov Dev 2005;8:239-52.
17. Kersten B, Feilner T, Kramer A, Wehrmeyer S, Possling A, Witt I, et al. Generation of Arabidopsis protein chips for antibody and serum screening. Plant Mol Biol 2003;52:999-1010.
18. Haab BB. Advances in protein microarray technology for protein expression and interaction profiling. Curr Opin Drug Discov Dev 2001;4:116-23.
19. Kumble KD. Protein microarrays: new tools for pharmaceutical development. Anal Bioanal Chem 2003;377:812-19.
20. MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science 2000;289:1760-3.
21. Templin MF, Stoll D, Schrenk M, Traub PC, Vohringer CF, Joos TO. Protein microarray technology. Drug Discov Today 2002;7:815-22.
22. Kodadek T. Protein microarrays: prospects and problems. Chem Biol 2001;8:105-15.
23. Schweitzer B, Predki P, Snyder M. Microarrays to characterize protein interactions on a whole-proteome scale. Proteomics 2003;3:2190-9.
24. Lueking A, Cahill DJ, Mullner S. Protein biochips: a new and versatile platform technology for molecular medicine. Drug Discov Today 2005;10:789-94.
25. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight, et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000;403:623-7.
26. Qureshi AE, Cagney G. Large-scale functional analysis using peptide or protein arrays. Nat Biotechnol 2000;18:393-7.
27. Junaid Z, David MS. Microarrays of cells expressing defined cDNAs. Nature 2001;411:107-10.
28. Mousses S, Caplen NJ, Cornelison R, Weaver D, Basik M, Hautaniemi S, et al. RNAi microarray analysis in cultured mammalian cells. Genome Res 2003;13:2341-7.
29. Kit SL, Manat R. From combinatorial chemistry to chemical microarray. Curr Opin Chem Biol 2002;6:353-8.
30. Dickopf S, Frank HD, Junker S, Maier G, Metz H, Ottleben H, et al. Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa. Anal Biochem 2004;335:50-7.
31. Barret JC, Kawasaki ES. Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression. Drug Discov Today 2003;8:134-41.
32. Sinibaldi R. Gene expression analysis and drug R&D. Drug Discov World 2003;5:37-43.
33. Sheils O, Finn S, O'Leary J. Nucleic acid microarrays: an overview. Curr Diagn Pathol 2003;9:155-8.
34. Sauter G, Simon R. Predictive molecular pathology. N Engl J Med 2002;347:1995-6.
35. , http://www.ncbi.nlm.nih.gov/About/primer/microarrays.html.
36. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
37. Yu W, Ballif BC, Kashank CD, Heilstedt HA, Howard LA, Cai WW, et al. Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-charcterized 1p36 deletions. Hum Mol Genet 2003;12:2145-52.
38. Pettus JA, Cowley BC, Maxwell T, Milash B, Stephenson RA, Rohr LR, et al. Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics. Cancer Genet Cytogenet 2004;154:110-18.
39. Shaw CJ, Shaw CA, Yu W, Stankiewicz P, White LD, Beaudet AL, et al. Comparative genomic hybridisation using a proximal 17pBAC/PAC array detects rearrangements responsible for four genomic disorders. J Med Genet 2004;41:113-19.
40. Strohmeyer DM, Berger AP, Moore DH II, Bartsch G, Klocker H, Carroll PR, et al. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Prostate 2004;59:43-58.
41. Roerig P, Nessling M, Radlwimmer B, Joos S, Wrobel G, Schwaenen C, et al. Molecular classification of human gliomas using matrix-based comparative genomic hybridization. Int J Cancer 2005;117:95-103.
42. Oostlander A, Meijer G, Ylstra B. Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet 2004;66:488-95.
43. Diosdado B, Wapenaar MC, Franke L, Duran KJ, Goerres MJ, Hadithi M, et al. A microarray screen for novel candidate genes in coeliac disease pathogenesis. Gut 2004;53:944-51.
44. Kittleson MM, Hare JM. Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. Trends Cardiovasc Med 2005;15:130-8.
45. Gunther EC, Stone DJ, Gerwien RW, Bento P, Melvyn PH. Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci USA 2003;100:9608-13.
46. Ganter B, Tugendreich S, Pearson CI, Ayangolu E, Baumhueter S, Bostian KA, et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol 2005;119:219-44.
47. Villuendas R, Steegmann JL, Pollan M, Tracey L, Granda A, Fernandez-Ruiz E, et al. Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach. Leukemia 2006;20:1047-54.
48. Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, et al. Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. Cancer Res 2006;66:2765-77.
49. Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, et al. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 2006;98:825-38.
50. Hacia JG. Resequencing and mutational analysis using oligonucleotide microarrays. Nat Genet 1999;21:42-7.
51. Lindroos K, Sigurdsson S, Johansson K, Ronnblom L, Syvanen AC. Multiplex SNP genotyping in pooled DNA samples by a four-colour microarray system. Nucleic Acids Res 2002;30:e70..
52. Shi MM. Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes. Am J Pharmacogenomics 2002;2:197-205.
53. Irving JA, Bloodworth L, Bown NP, Case MC, Hogarth LA, Hall AG. Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis. Cancer Res 2005;65:3053-8.
54. Klevering BJ, Yzer S, Rohrschneider K, Zonneveld M, Allikmets R, van den Born LI, et al. Microarray-based mutation analysis of the ABCA4 (ABCR) gene in autosomal recessive cone-rod dystrophy and retinitis pigmentosa. Eur J Hum Genet 2004;12:1024-32.
55. Janecke AR, Thompson DA, Utermann G, Becker C, Hubner CA, Schmid E, et al. Mutations in RDH12 encoding a photoreceptor cell retinol dehydrogenase cause childhood-onset severe retinal dystrophy. Nat Genet 2004;36:850-4.
56. Patwardhan B. Ethnopharmacology and drug discovery. J Ethnopharmacol 2005;100:50-2.
57. Heinrich M. Ethnobotany and natural products: the search for new molecules, new treatments of old diseases or a better understanding of indigenous cultures?. Curr Top Med Chem 2003;3:141-54.
58. Vuorela P, Leinonen M, Saikku P, Tammela P, Rauha JP, Wennberg T, et al. Natural products in the process of finding new drug candidates. Curr Med Chem 2004;11:1375-89.
59. Wermuth CG. Multitargeted drugs: the end of the 'one-target-one-disease' philosophy?. Drug Discov Today 2004;9:826-7.
60. Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 2005;26:178-82.
61. Cappuzzo F, Finocchiaro G, Trisoloini R, Toschi L, Bartolini S, Metro G, et al. Perspectives on salvage therapy for non-small-cell lung cancer. Oncology 2005;19:989-95.
62. Amagaya S, Iizuka A, Makino B, Kubo M, Komatsu Y, Cheng FC, et al. General pharmacological properties of Sho-seiryu-to (TJ-19) extracts. Phytomedicine 2001;8:338-47.
63. Ye F, Wang H, Jiang S, Wu J, Shao J, Cheng X, et al. Quality evaluation of commercial extracts of Scutellaria baicalensis. Nutr Cancer 2004;49:217-22.
64. Wagner H. New approaches in phytopharmacological research. Pure Appl Chem 1999;71:1649-54.
65. Clarke PA, te Poele R, Wooster R, Workman P. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol 2001;62:1311-36.
66. Butte A. The use and analysis of microarray data. Nat Rev Drug Discov 2002;1:951-60.
67. Crowther DJ. Applications of microarrays in the pharmaceutical industry. Curr Opin Pharmacol 2002;2:551-4.
68. Klapa MI, Quackenbush J. The quest for the mechanisms of life. Biotechnol Bioeng 2003;84:739-42.
69. Coldren CD, Hashim P, Ali JM, Oh SK, Sinskey AJ, Rha C. Gene expression changes in the human fibroblast induced by Centella asiatica triterpenoids. Planta Med 2003;69:725-32.
70. Iizuka N, Oka M, Yamamoto K, Tangoku A, Miyamoto K, Miyamoto T, et al. Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray. Int J Cancer 2003;107:666-72.
71. Zhuang WJ, Fong CC, Cao J, Ao L, Leung CH, Cheung HY, et al. Involvement of NF-kappa B and c-myc signaling pathways in the apoptosis of HL-60 cells induced by alkaloids of Tripterygium hypoglaucum (levl.). Hutch Phytomedicine 2004;11:295-302.
72. Li X, Hu Y. Gene expression profiling reveals the mechanism of action of anticonvulsant drug QYS. Brain Res Bull 2005;66:99-105.
73. Li ZS, Li DL, Huang J, Ding Y, Ma BP, Wang SQ. Investigations on the molecular mechanisms of saponins from Anemarrhena asphodeloides Bunge using oligonucleotide microarrays. Yao Xue Xue Bao 2003;38:496-500, [Chinese].
74. Chen Y, Shen ZY, Chen WH. Molecular mechanism of epimedium flavonoids in immune homeostasis remodeling in aged rats revealed by lymphocyte gene expression profile. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24:59-62, [Chinese].
75. Wang Z, Du Q, Wang F, Liu Z, Li B, Wang A, et al. Microarray analysis of gene expression on herbal glycoside recipes improving deficient ability of spatial learning memory in ischemic mice. J Neurochem 2004;88:1406-15.
76. Freeman WM, Brebner K, Lynch WJ, Robertson DJ, Roberts DC, Vrana KE. Cocaine-responsive gene expression changes in rat hippocampus. Neuroscience 2001;108:371-80.
77. McClung CA, Nestler EJ, Zachariou V. Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J Neurosci 2005;25:6005-15.
78. Liu L, Han L, Wong DY, Yue PY, Ha WY, Hu YH, et al. Effects of Si-Jun-Zi decoction polysaccharides on cell migration and gene expression in wounded rat intestinal epithelial cells. Br J Nutr 2005;93:21-9.
79. Li Y, Hong X, Hussain M, Sarkar SH, Li R, Sarkar FH. Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Mol Cancer Ther 2005;4:389-98.
80. Christen Y, Olano-Martin E, Packer L. Egb 761 in the postgenomic era: new tools from molecular biology for the study of complex products such as Ginkgo biloba extract. Cell Mol Biol 2002;48:593-9.
81. Watanabe CM, Wolffram S, Ader P, Rimbach G, Packer L, Maguire, et al. The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc Natl Acad Sci USA 2001;98:6577-80.
82. Smith JV, Burdick AJ, Golik P, Khan I, Wallace D, Luo Y. Antiapoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell Mol Biol 2002;48:699-707.
83. Li W, Pretner E, Shen L, Drieu K, Papadopoulos V. Common gene targets of Ginkgo biloba extract (EGb 761) in human tumor cells: relation to cell growth. Cell Mol Biol 2002;48:655-62.
84. De Feudis FV, Papadopoulos V, Drieu K. Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol 2003;17:405-17.
85. Roy S, Khanna S, Shah H, Rink C, Phillips C, Preuss H, et al. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol 2005;24:244-55.
86. Lee SM, Li ML, Tse YC, Leung SC, Lee MM, Tsui SK, et al. Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sci 2002;71:2267-77.
87. Yin X, Zhou J, Jie C, Xing D, Zhang Y. Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci 2004;75:2233-44.
88. Prasad RC, Herzog B, Boone B, Sims L, Waltner-Law M. An extract of Syzygium aromaticum represses genes encoding hepatic gluconeogenic enzymes. J Ethnopharmacol 2005;96:295-301.
89. Bagchi D, Sen CK, Ray SD, Das DK, Bagchi M, Preuss HG, et al. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003;523-524:87-97.
90. Wong ML, O'Kirwan F, Hannestad JP, Irizarry KJ, Elashoff D, Licinio J. St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol Psychiatr 2004;9:237-51.
91. Katz S, Harris R, Tien-Yau Lau J, Chau A. The use of gene expression analysis and proteomic databases in the development of a screening system to determine the value of natural medicinal products. Evid Based Complement Alternat Med 2006;3:1-6.
92. Yang NS, Shyur LF, Chen CH, Wang SY, Tzeng CM. Medicinal herb extract and a single-compound drug confer similar complex pharmacogenomic activities in mcf-7 cells. J Biomed Sci 2004;11:418-22.
93. Rushmore TH, Kong AN. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 2002;3:481-90.
94. Liljedahl U, Karlsson J, Melhus H, Kurland L, Lindersson M, Kahan T, et al. A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. Pharmacogenetics 2003;13:7-17.
95. Amin RP, Hamadeh HK, Bushel PR, Bennett L, Afshari CA, Paules RS. Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology 2002;181:555-63.
96. Waring JF, Gum R, Morfitt D, Jolly RA, Ciurlionis R, Heindel M, et al. Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor. Toxicology 2002;181:537-50.
97. Pennie WD. Custom cDNA microarrays; technologies and applications. Toxicology 2002;181-182:551-4.
98. Ko SY, Lin SC, Chang KW, Liu CJ, Chang SS, Lu SY, et al. Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract. J Oral Pathol Med 2003;32:399-407.
99. Tsai WC, Tsai ST, Ko JY, Jin YT, Li C, Huang W, et al. The mRNA profile of genes in betel quid chewing oral cancer patients. Oral Oncol 2004;40:418-26.
100. Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134-8.
101. Coxeter PD, McLachlan AJ, Duke CC, Roufogalis BD. Herb-drug interactions: an evidence based approach. Curr Med Chem 2004;11:1513-25.
102. Bonham MJ, Galkin A, Montgomery B, Stahl WL, Agus D, Nelson PS. Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition. J Natl Cancer Inst 2002;94:1641-7.
103. Bonham M, Arnold H, Montgomery B, Nelson PS. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma. Cancer Res 2002;62:3920-4.
104. Joshi K, Chavan P, Warude D, Patwardhan B. Molecular markers in herbal drug technology. Curr Sci 2004;87:159-65.
105. Warude D, Chavan P, Joshi K, Patwardhan B. Isolation of DNA from fresh and dry samples having highly acidic tissues. Plant Mol Biol Rep 2003;21:1-6.
106. Carles M, Lee T, Moganti S, Lenigk R, Tsim KW, Ip NY, et al. Chips and Qi: microcomponent-based analysis in traditional Chinese medicine. Fresenius J Anal Chem 2002;371:190-4.
107. Trau D, Lee TM, Lao AI, Lenigk R, Hsing IM, Ip NY. Genotyping on a complementary metal oxide semiconductor silicon polymerase chain reaction chip with integrated DNA microarray. Anal Chem 2002;74:3168-73.
108. Tsoi PY, Wu HS, Wong MS, Chen SL, Fong WF, Xiao, et al. Genotyping and species identification of Fritillaria by DNA chip technology. Acta Pharm Sin 2003;4:185-190.
109. Zhang YB, Wang J, Wang ZT, But PP, Shaw PC. DNA microarray for identification of the herb of dendrobium species from Chinese medicinal formulations. Planta Med 2003;69:1172-4.
110. Carles M, Cheung MK, Moganti S, Dong TT, Tsim KW, Ip NY, et al. A DNA microarray for the authentication of toxic traditional Chinese medicinal plants. Planta Med 2005;71:580-4.
111. Patwardhan B. Ayugenomics: integration for customized medicine. Indian J Nat Products 2003;19:16-23.
112. Kung PC, Cheng YC. Phytomics: a genomic-based approach to herbal compositions. , WIPO Patent No. WO 00/24934, 4 May 2000.
113. Ventura C. CAM and cell fate targeting: molecular and energetic insights into cell growth and differentiation. Evid Based Complement Alternat Med 2005;2:277-83.
114. Blower PE, Yang C, Fligner MA, Verducci JS, Yu L, Richman S, et al. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J 2002;2:259-71.
115. Tonisson N, Zernant J, Kurg A, Pavel H, Slavin G, Roomere H, et al. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene. Proc Natl Acad Sci USA 2002;99:5503-8.
116. Hacia JG, Collins FS. Mutational analysis using oligonucleotide microarrays. J Med Genet 1999;36:730-6.
117. Lin B, Wang Z, Vora GJ, Thornton JA, Schnur JM, Thach DC, et al. Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays. Genome Res 2006;16:527-35.
118. Gerry NP, Witowski NE, Day J, Hammer RP, Barany G, Barany F. Universal DNA microarray method for multiplex detection of low abundance point mutations. J Mol Biol 1999;292:251-62.
119. Favis R, Day JP, Gerry NP, Phelan C, Narod S, Barany F. Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 2000;18:561-4.
120. Syvanen AC. Toward genome-wide SNP genotyping. Nat Genet 2005;37:5-10.
121. King HC, Sinha AA. Gene expression profile analysis by DNA microarrays: promise and pitfalls. J Am Med Assoc 2001;286:2280-8.
122. Kothapalli R, Yoder SJ, Mane S, Loughran TP. Microarray results: how accurate are they? BMC Bioinformatics 2002;3:22.
123. Chuaqui RF, Bonner RF, Best CJM, Gillespie JW, Flaig MJ, Hewitt SM, et al. Post analysis follow-up and validation of microarray experiments. Nat Genet 2002;32:509-13.
124. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001;29:365-71.
125. Churchill GA. Fundamentals of experimental design for cDNA microarrays. Nat Genet 2002;32:490-5.
126. Fathallah-Shaykh H, He B, Zhao L-J, Badruddin A. A mathematical algorithm for discovering states of expression from direct genetic comparison by microarrays. Nucleic Acids Res 2004;32:3807-14.
127. Fathallah-Shaykh H. Microarrays: applications and pitfalls. Arch Neurol 2005;62:1669-72.